07:32 AM EDT, 09/03/2024 (MT Newswires) -- Calliditas Therapeutics ( CALT ) said Tuesday that its board of directors has resolved to apply for the delisting of the company's common shares from Nasdaq Stockholm and its American depositary shares from the Nasdaq Global Select Market as Asahi Kasei is about to complete its takeover.
Calliditas said Asahi Kasei announced Monday that it controls more than 90% of the outstanding shares of Calliditas and plans to buy all the remaining shares of the company.
The company said it plans to file a Form 25 with the US Securities and Exchange Commission around Sept. 13 and expects the delisting of its American depositary shares to become effective around Sept. 23.
Asahi Kasei, in a separate statement Tuesday, said Calliditas will become its subsidiary on Sept. 9.